Summary
The haemodynamic effects of i.v. bolus injections of 100 and 200 µg ovine CRF and human CRF in man have been compared. Neither ovine CRF 100 µg nor human CRF 100 µg caused a significant change in blood pressure, although the pulse rate was increased in all the subjects tested. The mean maximum increase in pulse rate after human CRF was almost twice that after ovine CRF (21 vs 12 beats·min−1;p<0.05). After 200 µg ovine CRF in all subjects the diastolic blood pressure declined gradually from 77 mm Hg to a nadir of 67 mm Hg at 22 min (p<0.002). After 200 µg human CRF diastolic blood pressure fell from 78 mm Hg to a nadir of 61 mm Hg at 6 min (p<0.002); the fall after human CRF was significantly greater than after ovine CRF (p<0.05). After 200 µg ovine CRF there was a slight increase in pulse rate lasting for 6 min, and after 200 µg human CRF there was a marked (reflex) tachycardia for 30 min. Only after the highest dose of human CRF did a slight increase in systolic blood pressure occur. The haemodynamic effects of both doses of human CRF were accompanied by significant increases in plasma noradrenaline concentrations, which were significantly greater after the higher dose.
Similar content being viewed by others
References
Brown M, Fisher L (1983) Central nervous system effects of corticotropin releasing factor in the dog. Brain Res 280: 75–79
Brown M, Fisher L, Spiess J, Rivier J, Rivier C, Vale W (1982) Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept 4: 107–114
Chrousos G, Schulte H, Oldfield E, Gold P, Cutler G, Loriaux D (1984) The corticotropin-releasing factor stimulation test: An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 310: 622–626
Fisher L, Jessen G, Brown M (1983) Corticotropin-releasing factor (CRF): Mechanism to elevate mean arterial pressure and heart rate. Regul Pept 5: 153–161
Fisher L, Rivier J, Rivier C, Spiess J, Vale W, Brown M (1982) Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heart rate in rats. Endocrinology 110: 2222–2224
Hermus A, Pieters G, Pesman G, Buijs W, Smals A, Benraad T, Kloppenborg P (1984) Differential effects of ovine and human corticotrophin-releasing factor in human subjects. Clin Endocrinol 21: 589–595
Hermus A, Pieters G, Pesman G, Smals A, Benraad T, Kloppenborg P (1985) ACTH and cortisol responses to ovine corticotrophin-releasing factor in patients with primary and secondary adrenal failure. Clin Endocrinol 22: 761–769
Hermus A, Raemaekers J, Pieters G, Bartelink A, Smals A, Kloppenborg P (1983) Safety of corticotropin-releasing factor. Lancet 2: 112
Hoffmann J, Willemsen J, Thien T, Benraad T (1982) Radioenzymatic assay of plasma adrenaline and noradrenaline: Evidence for a catechol-0-methyl-transferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta 125: 319–327
Kalin N, Gonder J, Shelton S (1983a) Effects of synthetic ovine CRF on ACTH, cortisol, and blood pressure in sheep. Peptides 4: 221–223
Kalin N, Shelton S, Kraemer G, McKinney W (1982) Corticotropin-releasing factor causes hypotension in rhesus monkeys. Lancet 2: 1042
Kalin N, Shelton S, Kraemer G, McKinney W (1983b) Corticotropin-releasing factor administered intraventricularly to rhesus monkeys. Peptides 4: 217–220
MacCannell K, Lederis K, Hamilton P, Rivier J (1982) Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation. Pharmacology 25: 116–120
Müller O, Stalla G, von Werder K (1983) Corticotropin-releasing factor: a new tool for the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 57: 227–229
Orth D, Jackson R, De Cherney G, De Bold C, Alexander A, Island D, Rivier J, Rivier C, Spiess J, Vale W (1983) Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest 71: 587–595
Schürmeyer T, Avgerinos P, Gold P, Galluci W, Tomai T, Cutler G, Loriaux D, Chrousos, G (1984) Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab 59: 1103–1108
Scoggins B, Coghlan J, Denton D, Fei D, Nelson M, Tregear G, Tresham J, Wang X-M (1984) Intracerebroventricular infusion of corticotrophin-releasing factor (CRF) and ACTH raise blood pressure in sheep. Clin Exp Pharmacol Physiol 11: 365–368
Tsukada T, Nakai Y, Koh T, Tsujii S, Inada M, Nishikawa M, Shinoda H, Kawai J, Takezawa N, Imura H (1984) Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders. J Clin Endocrinol Metab 58: 758–760
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hermus, A.R.M.M., Pieters, G.F.F.M., Willemsen, J.J. et al. Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur J Clin Pharmacol 31, 531–534 (1987). https://doi.org/10.1007/BF00606625
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606625